This strategy also aided analysis of post-NAC cells, since estrogen receptor positive breast cancers are relatively resistant to chemotherapy as compared to other breast cancer subtypes [22], therefore increased numbers of post-therapy cells would be present. The gene discussed is ESR1; the disease is breast carcinoma.